AA
GTHX

ALPS Advisors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

ALPS Advisors’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-51,899
Closed -$696K – 992
2021
Q3 		$696K Sell
51,899
-3,518
-6% -$57.3K 0.01% 448
2021
Q2 		$1.22M Buy
+55,417
New +$1.23M 0.01% 383
2020
Q4 		– Sell
-48,478
Closed -$560K – 886
2020
Q3 		$560K Sell
48,478
-3,002
-6% -$49.6K 0.01% 410
2020
Q2 		$1.25M Sell
51,480
-16,844
-25% -$279K 0.02% 278
2020
Q1 		$753K Sell
68,324
-7,368
-10% -$138K 0.01% 343
2019
Q4 		$2M Buy
75,692
+840
+1% +$19.6K 0.02% 226
2019
Q3 		$1.71M Sell
74,852
-3,560
-5% -$112K 0.01% 229
2019
Q2 		$2.4M Sell
78,412
-11,404
-13% -$240K 0.02% 210
2019
Q1 		$1.49M Buy
89,816
+3,885
+5% +$73.7K 0.01% 263
2018
Q4 		$1.65M Buy
85,931
+26,817
+45% +$1M 0.01% 240
2018
Q3 		$3.09M Buy
59,114
+11,656
+25% +$636K 0.02% 201
2018
Q2 		$2.06M Buy
47,458
+9,307
+24% +$399K 0.01% 227
2018
Q1 		$1.41M Buy
38,151
+6,742
+21% +$180K 0.01% 254
2017
Q4 		$623K Buy
31,409
+3,643
+13% +$78.3K ﹤0.01% 371
2017
Q3 		$691K Buy
27,766
+2,317
+9% +$42.8K ﹤0.01% 310
2017
Q2 		$444K Buy
+25,449
New +$445K ﹤0.01% 620

Other funds holding GTHX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

ALPS Advisors's GTHX Position: Q4 2021 in Review

ALPS Advisors sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2021, closing a stake of 51,899 shares — an estimated $696K sold.

ALPS Advisors first reported a position in GTHX in Q2 2017 and held it in 16 quarters. The position peaked at $3.09M in Q3 2018. 108 funds tracked by Wall St. Rank hold GTHX as of Q4 2021.

  • ALPS Advisors reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • ALPS Advisors sold 51,899 G1 Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $696K.
  • ALPS Advisors first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2017 and held it in 16 quarters.
  • ALPS Advisors's G1 Therapeutics, Inc. Common Stock position peaked at $3.09M in Q3 2018.
  • 108 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2021.

Based on ALPS Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.